Pub Date : 2024-04-01Epub Date: 2023-06-26DOI: 10.1037/pha0000664
Casey Alexander, Nicholas J Bush, John K Neubert, Michael Robinson, Jeff Boissoneault
Although laboratory studies indicate alcohol reduces pain intensity and increases pain threshold, these effects likely do not completely explain perceived pain relief from alcohol intake. In this study, we tested expectancy of alcohol analgesia (EAA) as a moderator of subjective pain relief following oral alcohol challenge in individuals with and without chronic orofacial pain. Social drinkers (N = 48; 19 chronic pain; 29 pain-free controls) completed two testing sessions: alcohol administration (BrAC: 0.08 g/dL) and placebo. Alcohol expectancy (AE) was assessed using the EAA questionnaire and two 100-mm Visual Analogue Scales (VASs) regarding strength of belief that alcohol provides pain relief (AE VAS 1) or reduces pain sensitivity (AE VAS 2). Participants completed quantitative sensory testing (QST) involving application of pressure to the masseter insertion. Pain threshold (lbf; three repetitions) and pain intensity (4, 5, and 6 lbf; three repetitions each; 100-mm VAS) were collected. After each stimulus, participants rated perceived pain relief due to consumption of the study beverage (0-100 VAS). Higher EAA and AE VAS 1 ratings were associated with stronger perceived relief in the alcohol, but not placebo, condition. However, expectancy specifically related to reduction in pain sensitivity (AE VAS 2) was not associated with relief. Additionally, changes in pain threshold and intensity were not significantly correlated with perceived relief. Taken together, results suggest expectancy that alcohol provides pain relief is an important determinant of its negative reinforcing effects. Future studies should investigate challenging these expectancies as a means of reducing alcohol-related risk in people with pain. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
尽管实验室研究表明,酒精可以降低疼痛强度并提高疼痛阈值,但这些影响可能并不能完全解释饮酒后的疼痛缓解。在这项研究中,我们测试了酒精镇痛(EAA)作为口服酒精刺激后主观疼痛缓解的调节因子的预期值,用于患有和不患有慢性口腔面部疼痛的个体。社交饮酒者(N=48;19名慢性疼痛患者;29名无疼痛对照者)完成了两次测试:酒精给药(BrAC:0.08g/dL)和安慰剂。使用EAA问卷和两个100 mm视觉模拟量表(VAS)评估酒精预期(AE),评估酒精提供疼痛缓解(AE VAS 1)或降低疼痛敏感性(AE VAS 2)的信念强度。参与者完成了定量感觉测试(QST),包括对咬肌插入施加压力。收集疼痛阈值(lbf;三次重复)和疼痛强度(4、5和6 lbf;每次重复三次;100 mm VAS)。每次刺激后,参与者对因饮用研究饮料而感知到的疼痛缓解进行评分(0-100 VAS)。较高的EAA和AE VAS 1评分与更强的酒精缓解相关,但与安慰剂无关。然而,与疼痛敏感性降低特别相关的预期(AE VAS 2)与缓解无关。此外,疼痛阈值和强度的变化与感知缓解没有显著相关性。总之,研究结果表明,期望酒精能缓解疼痛是其负面强化作用的重要决定因素。未来的研究应该调查挑战这些预期,作为降低疼痛患者与酒精相关风险的一种手段。(PsycInfo数据库记录(c)2023 APA,保留所有权利)。
{"title":"Expectancy of alcohol analgesia moderates perception of pain relief following acute alcohol intake.","authors":"Casey Alexander, Nicholas J Bush, John K Neubert, Michael Robinson, Jeff Boissoneault","doi":"10.1037/pha0000664","DOIUrl":"10.1037/pha0000664","url":null,"abstract":"<p><p>Although laboratory studies indicate alcohol reduces pain intensity and increases pain threshold, these effects likely do not completely explain perceived pain relief from alcohol intake. In this study, we tested expectancy of alcohol analgesia (EAA) as a moderator of subjective pain relief following oral alcohol challenge in individuals with and without chronic orofacial pain. Social drinkers (<i>N</i> = 48; 19 chronic pain; 29 pain-free controls) completed two testing sessions: alcohol administration (BrAC: 0.08 g/dL) and placebo. Alcohol expectancy (AE) was assessed using the EAA questionnaire and two 100-mm Visual Analogue Scales (VASs) regarding strength of belief that alcohol provides pain relief (AE VAS 1) or reduces pain sensitivity (AE VAS 2). Participants completed quantitative sensory testing (QST) involving application of pressure to the masseter insertion. Pain threshold (lbf; three repetitions) and pain intensity (4, 5, and 6 lbf; three repetitions each; 100-mm VAS) were collected. After each stimulus, participants rated perceived pain relief due to consumption of the study beverage (0-100 VAS). Higher EAA and AE VAS 1 ratings were associated with stronger perceived relief in the alcohol, but not placebo, condition. However, expectancy specifically related to reduction in pain sensitivity (AE VAS 2) was not associated with relief. Additionally, changes in pain threshold and intensity were not significantly correlated with perceived relief. Taken together, results suggest expectancy that alcohol provides pain relief is an important determinant of its negative reinforcing effects. Future studies should investigate challenging these expectancies as a means of reducing alcohol-related risk in people with pain. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10749982/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9833553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Michael J Zvolensky, Justin M Shepherd, Salma Argueta, Andre Bizier, Bryce K Clausen, Julia D Buckner, Marcel A de Dios, Miguel Ángel Cano
There has been increased recognition that Hispanic/Latinx (hereinafter Hispanic) persons are a tobacco disparities group in the United States. Although some past work has found greater exposure to racial/ethnic discrimination is associated with indices of smoking among Hispanic persons, research has not explored the degree of negative emotional reactivity to racial/ethnic stress in terms of smoking processes. The present cross-sectional study served to evaluate the indirect effects of depressive and anxiety symptoms in terms of relations between racial/ethnic stress reactivity and cigarette dependence, severity of problems when trying to quit, and perceived barriers for quitting among Hispanic persons who smoke in the United States. Participants included 329 Hispanic adults who smoked cigarettes daily (Mage = 35.5 years; SD = 8.67; 37.4% female). Results indicated that depressive symptoms exerted a statistically significant indirect effect in the association between negative emotional reactivity to racial/ethnic stress and cigarette dependence and severity of problems when trying to quit, whereas anxiety symptoms maintained an indirect effect for perceived barriers for smoking cessation. The current findings help characterize the intricacies by which negative emotional reactivity to racial/ethnic stress is related to smoking behavior and beliefs among Hispanic persons who smoke. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
越来越多的人认识到,西班牙裔/拉丁裔(以下简称西班牙裔)是美国的一个烟草不平等群体。尽管过去的一些研究发现,拉美裔美国人更容易受到种族/民族歧视,这与他们的吸烟指数有关,但还没有研究从吸烟过程的角度探讨他们对种族/民族压力的负面情绪反应程度。本横断面研究旨在评估抑郁和焦虑症状对美国吸烟的拉美裔人群中种族/民族压力反应性与香烟依赖性、戒烟问题的严重程度以及戒烟障碍之间关系的间接影响。研究对象包括 329 名每天吸烟的西班牙裔成年人(年龄:35.5 岁;标准差:8.67;女性:37.4%)。研究结果表明,抑郁症状对种族/民族压力的负面情绪反应与香烟依赖和戒烟问题严重程度之间的关联具有统计学意义上的间接影响,而焦虑症状对戒烟障碍的感知具有间接影响。目前的研究结果有助于说明种族/民族压力的负面情绪反应与吸烟的西班牙裔人士的吸烟行为和信念之间的复杂关系。(PsycInfo Database Record (c) 2024 APA,保留所有权利)。
{"title":"Evaluating the indirect roles of anxiety and depressive symptoms in the relations between negative emotional reactivity to racial/ethnic stress and cigarette smoking among Hispanic adults who smoke.","authors":"Michael J Zvolensky, Justin M Shepherd, Salma Argueta, Andre Bizier, Bryce K Clausen, Julia D Buckner, Marcel A de Dios, Miguel Ángel Cano","doi":"10.1037/pha0000708","DOIUrl":"https://doi.org/10.1037/pha0000708","url":null,"abstract":"<p><p>There has been increased recognition that Hispanic/Latinx (hereinafter Hispanic) persons are a tobacco disparities group in the United States. Although some past work has found greater exposure to racial/ethnic discrimination is associated with indices of smoking among Hispanic persons, research has not explored the degree of negative emotional reactivity to racial/ethnic stress in terms of smoking processes. The present cross-sectional study served to evaluate the indirect effects of depressive and anxiety symptoms in terms of relations between racial/ethnic stress reactivity and cigarette dependence, severity of problems when trying to quit, and perceived barriers for quitting among Hispanic persons who smoke in the United States. Participants included 329 Hispanic adults who smoked cigarettes daily (<i>M</i><sub>age</sub> = 35.5 years; <i>SD</i> = 8.67; 37.4% female). Results indicated that depressive symptoms exerted a statistically significant indirect effect in the association between negative emotional reactivity to racial/ethnic stress and cigarette dependence and severity of problems when trying to quit, whereas anxiety symptoms maintained an indirect effect for perceived barriers for smoking cessation. The current findings help characterize the intricacies by which negative emotional reactivity to racial/ethnic stress is related to smoking behavior and beliefs among Hispanic persons who smoke. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140059036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Morgan L Ferretti, Taylor B Stanley, Erica N Peters, Marcel O Bonn-Miller, Jessica G Irons
Some individuals attempt to alleviate menstrual-related symptoms (MRS) by using cannabis and report having expectations that cannabis can improve MRS; however, no study has examined the effect of cannabinoids on MRS. The present study is a pre-post, randomized, open-label trial that aimed to examine the effects of oral cannabidiol (CBD) isolate for alleviating MRS. Participants were assigned randomly to one of two open-label dosing groups of CBD softgels (160 mg twice a day, BID, n = 17; 320 mg BID, n = 16) and completed a 1-month baseline period. Following baseline, participants were instructed to consume CBD starting the first day they believed they experienced symptoms each month and to take their assigned dose daily for 5 consecutive days for three CBD-consumption months. We examined differences in MRS and related outcomes between baseline and 3 months of CBD consumption. Results revealed reductions (in both dosing groups) in MRS, irritability, anxiety, global impression of change, stress, and subjective severity scores when comparing baseline to all 3 months of CBD consumption. Depression scores did not change in either dosing group. Findings suggest that CBD may have the potential for managing MRS. Importantly, changes in symptoms appeared in the first month of CBD consumption and persisted over the 3 consumption months. Further research is warranted comparing the effects of CBD to placebo (a limitation of the study) and examining the potential to optimize CBD consumption for reducing MRS (e.g., combining CBD with terpenes; varying routes and timing of administration). (PsycInfo Database Record (c) 2024 APA, all rights reserved).
{"title":"Examination of the effects of cannabidiol on menstrual-related symptoms.","authors":"Morgan L Ferretti, Taylor B Stanley, Erica N Peters, Marcel O Bonn-Miller, Jessica G Irons","doi":"10.1037/pha0000709","DOIUrl":"https://doi.org/10.1037/pha0000709","url":null,"abstract":"<p><p>Some individuals attempt to alleviate menstrual-related symptoms (MRS) by using cannabis and report having expectations that cannabis can improve MRS; however, no study has examined the effect of cannabinoids on MRS. The present study is a pre-post, randomized, open-label trial that aimed to examine the effects of oral cannabidiol (CBD) isolate for alleviating MRS. Participants were assigned randomly to one of two open-label dosing groups of CBD softgels (160 mg twice a day, BID, <i>n</i> = 17; 320 mg BID, <i>n</i> = 16) and completed a 1-month baseline period. Following baseline, participants were instructed to consume CBD starting the first day they believed they experienced symptoms each month and to take their assigned dose daily for 5 consecutive days for three CBD-consumption months. We examined differences in MRS and related outcomes between baseline and 3 months of CBD consumption. Results revealed reductions (in both dosing groups) in MRS, irritability, anxiety, global impression of change, stress, and subjective severity scores when comparing baseline to all 3 months of CBD consumption. Depression scores did not change in either dosing group. Findings suggest that CBD may have the potential for managing MRS. Importantly, changes in symptoms appeared in the first month of CBD consumption and persisted over the 3 consumption months. Further research is warranted comparing the effects of CBD to placebo (a limitation of the study) and examining the potential to optimize CBD consumption for reducing MRS (e.g., combining CBD with terpenes; varying routes and timing of administration). (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140059037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rachel Ayala Guzman, Olivia L Bolts, Jennifer L Shipley, Megan Strowger, Mark A Prince, Abby L Braitman
College students consistently report problematic alcohol use (e.g., excessive drinking). Protective behavioral strategies (PBS) are behaviors for reducing alcohol use and/or problems and are negatively associated with alcohol misuse among college students. Studies suggest PBS are used more often and/or more effectively by female individuals. Additionally, examinations specifically between Black and White students have yielded mixed findings and are typically underpowered. Scant studies have investigated the intersectionality between race and gender or examined perceived effectiveness of PBS use related to alcohol outcomes. The current cross-sectional study examined if (a) race, (b) gender, and (c) their interaction moderate the associations between perceived effectiveness of PBS use on PBS use (a path) and between PBS use on alcohol outcomes (i.e., alcohol quantity, peak drinks, and problems; b path). A sample size of N = 528 college drinkers ages 18-24 years old (Mage = 19.85; 52.5%, Black, 40.3% White) completed an online survey and were used for analyses. A series of moderated mediation models were conducted. Race did not moderate the a or b paths. The positive association for the a path as well as the indirect effect of PBS perceived effectiveness on lower alcohol outcomes through PBS use were stronger for female students than male students. The intersectionality examination indicated a stronger association between more PBS use and lower consumption, specifically for White male students, and lower problems for Black female students. More attention is needed toward considering intersectionality when identifying at-risk groups and tailoring alcohol intervention efforts. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
大学生经常报告有饮酒问题(如过度饮酒)。保护性行为策略(PBS)是减少酒精使用和/或问题的行为,与大学生的酒精滥用呈负相关。研究表明,女性更经常和/或更有效地使用 PBS。此外,专门针对黑人和白人学生的研究结果也不尽相同,而且通常研究力量不足。很少有研究对种族和性别之间的交叉性进行调查,也很少有研究对与酒精结果相关的 PBS 使用效果进行调查。目前的横断面研究考察了(a)种族、(b)性别和(c)它们之间的相互作用是否会缓和PBS使用的感知有效性与PBS使用之间的关联(a路径)以及PBS使用与酒精结果(即酒精量、最高饮酒量和问题;b路径)之间的关联。完成在线调查并用于分析的样本量为 N = 528 名 18-24 岁的大学生饮酒者(年龄 = 19.85;52.5% 为黑人,40.3% 为白人)。我们建立了一系列调节中介模型。种族并没有调节 a 或 b 路径。与男生相比,女生在 a 路径上的正相关性以及通过使用公共健康教育系统对降低酗酒结果的间接影响更强。交叉性研究表明,使用更多的公共健康教育计划与降低饮酒量之间的关联性更强,尤其是对白人男生而言,而对黑人女生而言,问题更少。在识别高危人群和调整酒精干预措施时,需要更多地关注交叉性。(PsycInfo Database Record (c) 2024 APA, 版权所有)。
{"title":"A cross-sectional examination of race, gender, and intersectionality on protective behavioral strategies and alcohol outcomes among Black and White college students.","authors":"Rachel Ayala Guzman, Olivia L Bolts, Jennifer L Shipley, Megan Strowger, Mark A Prince, Abby L Braitman","doi":"10.1037/pha0000712","DOIUrl":"10.1037/pha0000712","url":null,"abstract":"<p><p>College students consistently report problematic alcohol use (e.g., excessive drinking). Protective behavioral strategies (PBS) are behaviors for reducing alcohol use and/or problems and are negatively associated with alcohol misuse among college students. Studies suggest PBS are used more often and/or more effectively by female individuals. Additionally, examinations specifically between Black and White students have yielded mixed findings and are typically underpowered. Scant studies have investigated the intersectionality between race and gender or examined perceived effectiveness of PBS use related to alcohol outcomes. The current cross-sectional study examined if (a) race, (b) gender, and (c) their interaction moderate the associations between perceived effectiveness of PBS use on PBS use (<i>a</i> path) and between PBS use on alcohol outcomes (i.e., alcohol quantity, peak drinks, and problems; <i>b</i> path). A sample size of <i>N</i> = 528 college drinkers ages 18-24 years old (<i>M</i><sub>age</sub> = 19.85; 52.5%, Black, 40.3% White) completed an online survey and were used for analyses. A series of moderated mediation models were conducted. Race did not moderate the <i>a</i> or <i>b</i> paths. The positive association for the a path as well as the indirect effect of PBS perceived effectiveness on lower alcohol outcomes through PBS use were stronger for female students than male students. The intersectionality examination indicated a stronger association between more PBS use and lower consumption, specifically for White male students, and lower problems for Black female students. More attention is needed toward considering intersectionality when identifying at-risk groups and tailoring alcohol intervention efforts. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140059034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Supplemental Material for Initial Evidence of the Acute Effect of Electronic Nicotine Delivery System Use on Energy Intake","authors":"","doi":"10.1037/pha0000710.supp","DOIUrl":"https://doi.org/10.1037/pha0000710.supp","url":null,"abstract":"","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139843209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Supplemental Material for Initial Evidence of the Acute Effect of Electronic Nicotine Delivery System Use on Energy Intake","authors":"","doi":"10.1037/pha0000710.supp","DOIUrl":"https://doi.org/10.1037/pha0000710.supp","url":null,"abstract":"","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139783363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Whether current suicide risk or a history of attempted suicide is related to the antidepressant effect of a low-dose ketamine infusion remains unclear. In total, 47 patients with treatment-resistant depression (TRD), including 32 with low current suicide risk and 15 with moderate or high current suicide risk, were randomized to groups receiving a low-dose ketamine infusion of either 0.2 or 0.5 mg/kg. Among the patients, 21 had a lifetime history of attempted suicide. Suicide risk was assessed based on the Suicidal scale of the Mini-International Neuropsychiatric Interview. The 17-item Hamilton Depression Rating Scale (HDRS) was used to measure depressive symptoms at baseline, at 40 and 240 min after infusion, and sequentially on Days 2-7 and 14 after ketamine infusion. Generalized estimating equation models indicated that the time effects of both 0.5 and 0.2 mg/kg ketamine infusions were significant during the study period. The models also indicated that current suicide risk (p = .037) but not lifetime history of attempted suicide (p = .184) was related to the trajectory of total HDRS scores. Patients with moderate-to-high current suicide risk benefited more from the low-dose ketamine infusion compared with those with the low current suicide risk. Patients with TRD having moderate or high current suicide risk may be prioritized to receive a low-dose ketamine infusion, which may aid suicide prevention. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
{"title":"Current suicide risk, but not lifetime history of attempted suicide, predicts treatment response to low-dose ketamine infusion: Post Hoc analysis of adjunctive ketamine study of Taiwanese patients with treatment-resistant depression.","authors":"Wei-Chen Lin, Tung-Ping Su, Cheng-Ta Li, Shih-Jen Tsai, Pei-Chi Tu, Ya-Mei Bai, Mu-Hong Chen","doi":"10.1037/pha0000658","DOIUrl":"10.1037/pha0000658","url":null,"abstract":"<p><p>Whether current suicide risk or a history of attempted suicide is related to the antidepressant effect of a low-dose ketamine infusion remains unclear. In total, 47 patients with treatment-resistant depression (TRD), including 32 with low current suicide risk and 15 with moderate or high current suicide risk, were randomized to groups receiving a low-dose ketamine infusion of either 0.2 or 0.5 mg/kg. Among the patients, 21 had a lifetime history of attempted suicide. Suicide risk was assessed based on the Suicidal scale of the Mini-International Neuropsychiatric Interview. The 17-item Hamilton Depression Rating Scale (HDRS) was used to measure depressive symptoms at baseline, at 40 and 240 min after infusion, and sequentially on Days 2-7 and 14 after ketamine infusion. Generalized estimating equation models indicated that the time effects of both 0.5 and 0.2 mg/kg ketamine infusions were significant during the study period. The models also indicated that current suicide risk (<i>p</i> = .037) but not lifetime history of attempted suicide (<i>p</i> = .184) was related to the trajectory of total HDRS scores. Patients with moderate-to-high current suicide risk benefited more from the low-dose ketamine infusion compared with those with the low current suicide risk. Patients with TRD having moderate or high current suicide risk may be prioritized to receive a low-dose ketamine infusion, which may aid suicide prevention. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9480052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-01Epub Date: 2023-03-13DOI: 10.1037/pha0000644
Amanda M Palmer, Matthew J Carpenter, Nathaniel L Baker, Brett Froeliger, Madeline G Foster, Eric L Garland, Michael E Saladin, Benjamin A Toll
Despite decades of progress, cigarette smoking remains a significant contributor to disease burden. This effect is especially pronounced for specific priority populations, such as individuals who live in rural communities, in that the burden of tobacco smoking is greater among these groups than in urban areas and the general population. The present study aims to evaluate the feasibility and acceptability of two novel tobacco treatment interventions delivered through remote telehealth procedures to individuals who smoke in the state of South Carolina. Results also include exploratory analyses of smoking cessation outcomes. Study I evaluated savoring, a strategy based on mindfulness practices, alongside nicotine replacement therapy (NRT). Study II evaluated retrieval-extinction training (RET), a memory-modification paradigm alongside NRT. In Study I (savoring), recruitment and retention data showed high interest and engagement in the intervention components, and participants who received this intervention decreased cigarette smoking throughout the course of the treatment (ps < .05). In Study II (RET), results showed high interest and moderate engagement in treatment, although exploratory outcome analyses did not demonstrate significant treatment effects on smoking behaviors. Overall, both studies showed promise in generating interest among individuals who smoke in participating in remotely delivered, telehealth smoking cessation interventions with novel therapeutic targets. A brief savoring intervention appeared to have effects on cigarette smoking throughout treatment, whereas RET did not. Gaining insight from the present pilot study, future studies may improve the efficacy of these procedures and incorporate the treatment components into more robust available treatments. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
尽管取得了几十年的进步,吸烟仍然是造成疾病负担的一个重要因素。这种影响对特定的重点人群尤为明显,例如生活在农村社区的人,因为这些人群的吸烟负担比城市地区和普通人群更大。本研究旨在评估通过远程医疗程序向南卡罗来纳州吸烟者提供两种新型烟草治疗干预措施的可行性和可接受性。研究结果还包括对戒烟效果的探索性分析。研究 I 评估了 "品味"(一种基于正念实践的策略)和尼古丁替代疗法(NRT)。研究二评估了检索-消减训练(RET),这是一种与尼古丁替代疗法(NRT)相结合的记忆修正范式。在研究 I(品味)中,招募和保留数据显示,参与者对干预内容的兴趣和参与度很高,接受干预的参与者在整个治疗过程中吸烟量有所下降(PS < .05)。研究二(RET)的结果显示,参与者对治疗有较高的兴趣和适度的参与,但探索性结果分析并未显示出治疗对吸烟行为的显著影响。总之,这两项研究都表明,吸烟者有兴趣参与具有新治疗目标的远程医疗戒烟干预。在整个治疗过程中,简短的品味干预似乎对吸烟有影响,而 RET 则没有。从目前的试点研究中获得启示后,未来的研究可能会提高这些程序的疗效,并将治疗内容纳入更强大的可用治疗中。(PsycInfo Database Record (c) 2024 APA,保留所有权利)。
{"title":"Development of two novel treatments to promote smoking cessation: Savor and retrieval-extinction training pilot clinical trial findings.","authors":"Amanda M Palmer, Matthew J Carpenter, Nathaniel L Baker, Brett Froeliger, Madeline G Foster, Eric L Garland, Michael E Saladin, Benjamin A Toll","doi":"10.1037/pha0000644","DOIUrl":"10.1037/pha0000644","url":null,"abstract":"<p><p>Despite decades of progress, cigarette smoking remains a significant contributor to disease burden. This effect is especially pronounced for specific priority populations, such as individuals who live in rural communities, in that the burden of tobacco smoking is greater among these groups than in urban areas and the general population. The present study aims to evaluate the feasibility and acceptability of two novel tobacco treatment interventions delivered through remote telehealth procedures to individuals who smoke in the state of South Carolina. Results also include exploratory analyses of smoking cessation outcomes. Study I evaluated savoring, a strategy based on mindfulness practices, alongside nicotine replacement therapy (NRT). Study II evaluated retrieval-extinction training (RET), a memory-modification paradigm alongside NRT. In Study I (savoring), recruitment and retention data showed high interest and engagement in the intervention components, and participants who received this intervention decreased cigarette smoking throughout the course of the treatment (<i>p</i>s < .05). In Study II (RET), results showed high interest and moderate engagement in treatment, although exploratory outcome analyses did not demonstrate significant treatment effects on smoking behaviors. Overall, both studies showed promise in generating interest among individuals who smoke in participating in remotely delivered, telehealth smoking cessation interventions with novel therapeutic targets. A brief savoring intervention appeared to have effects on cigarette smoking throughout treatment, whereas RET did not. Gaining insight from the present pilot study, future studies may improve the efficacy of these procedures and incorporate the treatment components into more robust available treatments. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497721/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10237225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-01Epub Date: 2023-10-12DOI: 10.1037/pha0000681
Rebecca Kurnellas, Rose Marie Ward, Elizabeth Taylor, Margaret P Martinetti
College student-athletes represent a high-risk group for heavy alcohol consumption and negative alcohol-related consequences. Although college drinking correlates with access to low-cost alcohol, no study has examined demand, or the relationship between price and consumption, in student-athletes. Furthermore, the prevalence of anxiety, depression, and drinking to cope motives in student-athletes suggest athlete-specific risks of alcohol consumption that have not yet been examined in conjunction with demand. Therefore, the present study examined gender differences in alcohol demand, alcohol consumption, and anxiety and depressive symptoms in student-athletes (n = 118) and nonathletes (n = 78) at three colleges/universities. Participants completed the Alcohol Purchase Task and measures of alcohol-related behaviors and mental health. Observed demand indices including intensity (i.e., consumption at zero price), Omax (i.e., maximum expenditure), Pmax (i.e., price associated with Omax), and breakpoint-1, or BP₁ (i.e., highest price of nonzero consumption) were calculated at the individual level. The rate of change in demand elasticity (i.e., decrease in consumption relative to price increases) was calculated at the group level. Overall, students reported lower alcohol consumption at higher alcohol prices, but men reported higher alcohol consumption and demand intensity than women, student-athletes reported higher Omax than nonathletes, and student-athletes reported lower depressive symptoms than nonathletes. These findings support reducing access to low-cost alcohol in college drinking environments as a harm-reduction strategy, particularly for high-risk student populations, such as men and those involved in athletics. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
{"title":"Alcohol demand in college students: The roles of athletic involvement and gender.","authors":"Rebecca Kurnellas, Rose Marie Ward, Elizabeth Taylor, Margaret P Martinetti","doi":"10.1037/pha0000681","DOIUrl":"10.1037/pha0000681","url":null,"abstract":"<p><p>College student-athletes represent a high-risk group for heavy alcohol consumption and negative alcohol-related consequences. Although college drinking correlates with access to low-cost alcohol, no study has examined demand, or the relationship between price and consumption, in student-athletes. Furthermore, the prevalence of anxiety, depression, and drinking to cope motives in student-athletes suggest athlete-specific risks of alcohol consumption that have not yet been examined in conjunction with demand. Therefore, the present study examined gender differences in alcohol demand, alcohol consumption, and anxiety and depressive symptoms in student-athletes (<i>n</i> = 118) and nonathletes (<i>n</i> = 78) at three colleges/universities. Participants completed the Alcohol Purchase Task and measures of alcohol-related behaviors and mental health. Observed demand indices including intensity (i.e., consumption at zero price), <i>O</i><sub>max</sub> (i.e., maximum expenditure), <i>P</i><sub>max</sub> (i.e., price associated with <i>O</i><sub>max</sub>), and breakpoint-1, or BP₁ (i.e., highest price of nonzero consumption) were calculated at the individual level. The rate of change in demand elasticity (i.e., decrease in consumption relative to price increases) was calculated at the group level. Overall, students reported lower alcohol consumption at higher alcohol prices, but men reported higher alcohol consumption and demand intensity than women, student-athletes reported higher <i>O</i><sub>max</sub> than nonathletes, and student-athletes reported lower depressive symptoms than nonathletes. These findings support reducing access to low-cost alcohol in college drinking environments as a harm-reduction strategy, particularly for high-risk student populations, such as men and those involved in athletics. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41195878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-01Epub Date: 2023-05-25DOI: 10.1037/pha0000648
Victoria R Votaw, Cassandra L Boness, Elena R Stein, Ashley L Watts, Kenneth J Sher, Katie Witkiewitz
Several dimensional frameworks for characterizing heterogeneity in alcohol use disorder (AUD) have been proposed, including the Addictions Neuroclinical Assessment (ANA). The ANA is a framework for assessing individual variability within AUD across three domains corresponding to the proposed stages of the addiction cycle: reward (binge-intoxication stage), negative emotionality (withdrawal-negative affect stage), and cognitive control (preoccupation-anticipation stage). Recent work has evaluated the ANA's three-factor structure and construct validity, primarily in treatment-seekers with AUD. We extended this research by examining the factor structure, bias across alcohol use severity, longitudinal invariance, and concurrent and predictive validity of a novel assessment of the ANA domains in adults with past 12-month regular (10 + alcohol units/week) alcohol use. Participants recruited from Prolific (N = 732), a crowdsourced data collection platform, completed various self-report measures. A test-retest subsample (n = 234) completed these measures 30 days later. Split-half exploratory factor analysis and confirmatory factor analysis supported the three-factor structure of the ANA. The overall factor structure was invariant across 30 days. Concurrently and prospectively, ANA domains demonstrated convergent validity concerning theoretically aligned alcohol-related, psychological, and personality measures. However, there was evidence of poor discriminant validity, and several cognitive control and reward items demonstrated bias across alcohol use severity. Future research is needed to improve the measurement of ANA domains using multimodal indicators, examine longitudinal changes in domains and their relationship with alcohol use severity, characterize phenotypic subgroups based on relative levels of domains, and compare the utility of the ANA with other proposed frameworks for measuring AUD heterogeneity. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
目前已提出了几种用于描述酒精使用障碍(AUD)异质性的维度框架,其中包括成瘾神经临床评估(ANA)。ANA 是一个框架,用于评估 AUD 在三个领域的个体差异性,这三个领域分别对应于所提出的成瘾周期阶段:奖赏(狂欢-中毒阶段)、负性情绪(戒断-负性情绪阶段)和认知控制(专注-预期阶段)。最近的研究对 ANA 的三因素结构和建构有效性进行了评估,主要是针对 AUD 的寻求治疗者。我们扩展了这一研究,对过去 12 个月经常饮酒(10 个酒精单位/周)的成年人进行了 ANA 领域的新评估,检验了其因子结构、不同饮酒严重程度的偏差、纵向不变性、并发和预测有效性。从众包数据收集平台 Prolific(N = 732)招募的参与者完成了各种自我报告测量。一个测试-重测子样本(n = 234)在 30 天后完成了这些测量。分半探索性因子分析和确认性因子分析支持 ANA 的三因子结构。总体因子结构在 30 天内保持不变。同时,ANA 的各个域在与酒精相关的理论、心理和人格测量方面表现出了前瞻性的趋同效度。但是,有证据表明其判别效度较差,而且几个认知控制和奖赏项目在不同的酒精使用严重程度下表现出偏差。未来的研究需要使用多模式指标改进 ANA 领域的测量,检查领域的纵向变化及其与酒精使用严重程度的关系,根据领域的相对水平描述表型亚组的特征,并比较 ANA 与其他建议的 AUD 异质性测量框架的效用。(PsycInfo Database Record (c) 2024 APA,保留所有权利)。
{"title":"Examining the validity of the addictions neuroclinical assessment domains in a crowdsourced sample of adults with current alcohol use.","authors":"Victoria R Votaw, Cassandra L Boness, Elena R Stein, Ashley L Watts, Kenneth J Sher, Katie Witkiewitz","doi":"10.1037/pha0000648","DOIUrl":"10.1037/pha0000648","url":null,"abstract":"<p><p>Several dimensional frameworks for characterizing heterogeneity in alcohol use disorder (AUD) have been proposed, including the Addictions Neuroclinical Assessment (ANA). The ANA is a framework for assessing individual variability within AUD across three domains corresponding to the proposed stages of the addiction cycle: reward (binge-intoxication stage), negative emotionality (withdrawal-negative affect stage), and cognitive control (preoccupation-anticipation stage). Recent work has evaluated the ANA's three-factor structure and construct validity, primarily in treatment-seekers with AUD. We extended this research by examining the factor structure, bias across alcohol use severity, longitudinal invariance, and concurrent and predictive validity of a novel assessment of the ANA domains in adults with past 12-month regular (10 + alcohol units/week) alcohol use. Participants recruited from Prolific (<i>N</i> = 732), a crowdsourced data collection platform, completed various self-report measures. A test-retest subsample (<i>n</i> = 234) completed these measures 30 days later. Split-half exploratory factor analysis and confirmatory factor analysis supported the three-factor structure of the ANA. The overall factor structure was invariant across 30 days. Concurrently and prospectively, ANA domains demonstrated convergent validity concerning theoretically aligned alcohol-related, psychological, and personality measures. However, there was evidence of poor discriminant validity, and several cognitive control and reward items demonstrated bias across alcohol use severity. Future research is needed to improve the measurement of ANA domains using multimodal indicators, examine longitudinal changes in domains and their relationship with alcohol use severity, characterize phenotypic subgroups based on relative levels of domains, and compare the utility of the ANA with other proposed frameworks for measuring AUD heterogeneity. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11088344/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9522375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}